triazolam	Nefazodone	1	1	true	positive	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  		10767	31565	D014229	C051752
triazolam	Nefazodone	1	1	true	positive	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  		10767	31565	D014229	C051752
triazolam	Nefazodone	1	2	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	1	2	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	1	3	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	1	3	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	3	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	3	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	4	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	2	4	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	4	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	4	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	5	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	3	5	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	5	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	5	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	6	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	4	6	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	6	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	5	6	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	6	true	positive	In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	Nefazodone	6	6	true	positive	In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	C051752
triazolam	nefazodone	1	1	true	positive	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  		10767	31565	D014229	31565
triazolam	nefazodone	1	1	true	positive	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  		10767	31565	D014229	31565
triazolam	nefazodone	1	2	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	1	2	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	1	3	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	1	3	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	2	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	2	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	2	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	2	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  		10767	31565	D014229	31565
triazolam	nefazodone	2	3	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	2	3	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	2	4	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	2	4	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	3	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	1	true	negative	When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4-fold and peak concentrations increased 1.7-fold.  Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  		10767	31565	D014229	31565
triazolam	nefazodone	3	4	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	3	4	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	3	5	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	3	5	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	4	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	2	true	negative	Nefazodone plasma concentrations were unaffected by triazolam.  Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  		10767	31565	D014229	31565
triazolam	nefazodone	4	5	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	4	5	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	4	6	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	4	6	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	5	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	3	true	positive	Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.  If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  		10767	31565	D014229	31565
triazolam	nefazodone	5	6	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	5	6	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	4	true	positive	If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended.  Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	5	true	positive	Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly.  In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	6	true	positive	In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
triazolam	nefazodone	6	6	true	positive	In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used (see CONTRAINDICATIONS and PRECAUTIONS).  		10767	31565	D014229	31565
